Clinical Trial

Feasibility, Safety and Effectivity of an Exercise Intervention for Newly Diagnosed Multiple Myeloma Patients During Induction Therapy

Study acronym: GMMG-HD8-INDEX
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 18, 2025 (before its estimated June 27, 2026 completion). Its status may not reflect the trial's current state.
Summary
Physical exercise is an important supportive therapy for cancer patients, which improves quality of life and can effectively counteract the side effects of drug therapy. There is very little experience whether physical activity can also be performed safely by patients with malignant diseases that affect bone stability. This applies in particular to patients with multiple myeloma, a disease characterized by a monoclonal proliferation of plasma cells in the bone marrow and often accompanied by severe bony destruction. Aim of this exploratory randomized controlled trial is to evaluate feasibility, safety and effectivity of an orthopaedic-guided exercise intervention during induction therapy in newly diagnosed multiple myeloma patients.
Trial Details
NCT Number NCT07026799
Lead Sponsor University Hospital Heidelberg
Conditions Multiple Myeloma Bone Lesions
Enrollment 50 participants
Start Date 2023-04-14
Primary Completion 2026-06-27 (estimated)
Study Completion 2026-06-27 (estimated)
Updated on ClinicalTrials.gov 2025-06-18